证券记录 · 已归档季度
CVS
CVS Health Corp. · Healthcare · Medical - Healthcare Plans
22被追踪持有人
n/aΔ持有人
197.40M持有股份
$11.65B报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | +1 | 4.62M | $393.86M | +1 | −1 |
| Q2 2026 | 181 | +1 | 951.14M | $98.28B | +4 | −4 |
| Q1 2026 | 184 | -5 | 933.53M | $67.00B | +1 | −7 |
| Q4 2025 | 188 | -1 | 988.04M | $78.39B | +1 | −1 |
| Q3 2025 | 31 | +1 | 672.14M | $50.66B | +1 | −1 |
| Q2 2025 | 28 | +1 | 592.40M | $40.85B | +1 | n/a |
| Q1 2025 | 24 | 0 | 305.08M | $20.66B | +1 | −1 |
| Q4 2024 | 24 | -1 | 290.03M | $13.02B | +1 | −2 |
| Q3 2024 | 24 | +2 | 213.06M | $13.39B | +3 | −1 |
| Q2 2024 | 22 | n/a | 197.40M | $11.65B | n/a | n/a |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 61.68M | n/a | $3.64B | 2.2% | n/c | 1 | SEC ↗ |
| 2 | Capital World Investors ✦ | 56.02M | n/a | $3.31B | 0.5% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 25.90M | n/a | $1.53B | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (被动) | 14.90M | n/a | $880.06M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 10.24M | n/a | $604.56M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 6 | Glenview Capital ✦ | 9.16M | n/a | $541.13M | 11.5% | n/c | 1 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 5.29M | n/a | $310.72M | 0.5% | n/c | 1 | SEC ↗ ×5 |
| 8 | Harris Associates (Oakmark) ✦ | 4.73M | n/a | $279.26M | 0.5% | n/c | 1 | SEC ↗ ×2 |
| 9 | PRIMECAP Management ✦ | 3.36M | n/a | $198.58M | 0.1% | n/c | 1 | SEC ↗ |
| 10 | Arrowstreet Capital ✦ | 1.82M | n/a | $107.56M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Bridgewater Associates ✦ | 1.24M | n/a | $73.45M | 0.4% | n/c | 1 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 1.08M | n/a | $63.80M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 13 | Millennium Management ✦ | 636.90K | n/a | $37.62M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Adage Capital Partners ✦ | 351.56K | n/a | $20.76M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Wellington Management ✦ | 211.13K | n/a | $12.47M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 16 | GAMCO Investors ✦ | 167.21K | n/a | $9.88M | 0.1% | n/c | 1 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 145.92K | n/a | $8.62M | 0.1% | n/c | 1 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 144.11K | n/a | $8.51M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Two Sigma Investments ✦ | 97.45K | n/a | $5.76M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Marshall Wace ✦ | 90.73K | n/a | $5.36M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 21 | Fisher Asset Management ✦ | 73.70K | n/a | $4.35M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Markel Group ✦ | 47.00K | n/a | $2.78M | 0.0% | n/c | 1 | SEC ↗ ×2 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,848 持有人, 1.07B 股份, $73.55B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据